Abu Dhabi Stem Cells Centre pioneers first UAE tumour-infiltrating lymphocyte cancer therapy programme

Stem cells, often described as "miracle" cells, hold significant promise for revolutionary medical treatments but vary greatly in their capabilities and applications. There are three main types: adult, embryonic, and induced pluripotent stem cells (iPSCs), each with unique strengths and limitations. Adult stem cells, ethically sourced from donors or patients, can only regenerate cells from their tissue of origin and are currently used primarily in blood-related therapies. Embryonic stem cells offer greater versatility but face ethical and regulatory challenges, while iPSCs, derived from adult cells and enhanced by AI-driven models, show potential in regenerative medicine and disease resistance, including combating chronic conditions like Alzheimer's. Additionally, the Abu Dhabi Stem Cells Centre has pioneered a breakthrough in cancer treatment by isolating Tumour-Infiltrating Lymphocytes (TILs) for immunotherapy, marking a major advancement in personalized medicine. These developments underscore the need for robust research, regulation, and public trust to fully realize stem cells' therapeutic potential globally.